Title : Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial.

Pub. Date : 2020 Oct 13

PMID : 33049054






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 These data show that NPM1 mutations or CBF rearrangements identify favorable prognostic groups in patients with FLT3-TKD AMLs, independent of other factors, also in the context of midostaurin treatment. midostaurin nucleophosmin 1 Homo sapiens